AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2025

Dec 9, 2025

34576_dirs_2025-12-09_25c1a140-35e0-49f0-9223-44b976a0338a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2025-12-06

Reporting Person: Wettig Thane (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-06	Common Stock	F	259	$8.42	Disposed	24680	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	40	Indirect

Footnotes

F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.